4.2. PDAC Patients with Lower AHR Expression Exhibit Decreased PD1 and Significantly Decreased PD-L1 mRNA Expression, Indicating a Potential Dysregulation of the PD1/PD-L1 Pathway in Tumour Immunity. Here, PDCD1 is linked to neoplasm.